Table of Contents
SBI Contra Fund and Invesco India Contra Fund both belong to the equity category of Mutual Funds. Both the funds follow a contrarian investment strategy. contra funds are a type of Equity Fund where the fund manager bets against the prevailing Market trends by buying assets that are either depressed or under-performing at that point in time. A contrarian is an investment strategy where the fund manager keeps a strong watch on the market to identify those underperforming stocks which have great potential to grow in the future. To guide you in making a better investment decision, we have done a comparison between both SBI Contra Fund and Invesco India Contra Fund. Take a look!
SBI Contra Fund was launched in the year July 14, 1999, with an aim to provide a long-term Capital appreciation to the investors through contrarian Investing. Being an equity-oriented fund, SBI Contra Fund is suitable for investors with a high-risk appetite. As an investment strategy, SBI Contra Fund follows a combination of top-down and bottom-up approach to stock-picking. Some of the top holdings of the fund as on 31/05/2018 are Kotak Mahindra Bank Ltd, Bharti Airtel Ltd, Eigi Equipments Ltd, ICICI Bank Ltd, etc. SBI Contra Fund is currently managed by Dinesh Balachandran. The fund follows S&P BSE 500 Index as its benchmark.
Invesco India Contra Fund was launched in the year April 11, 2007. The fund aims to seek long-term capital appreciation by investing in equity and related instruments through contrarian investing. The fund invests its corpus in sound companies which are available at attractive valuations/undervalued or in turnaround phase. As on Jun 30, 2018 some of the top holdings of the scheme are HDFC Bank Ltd, Reliance Industries Ltd, Infosys Ltd, ICICI Bank Ltd, ITC Ltd, etc. Invesco India Contra Fund is jointly managed by Taher Badshah and Amit Ganatra.
Though these schemes belong to the same category, yet these schemes differ on various parameters. So, let us understand the parameters which are divided into four sections, namely, Basics Section, Performance Report, Yearly Performance Report, and Other Details Section.
This section compares the various elements such as Current NAV, Scheme Category, and Fincash Rating. To begin with the scheme category, it can be said that both the schemes SBI Contra Fund and Invesco India Contra Fund belong to the same category of equity fund. With respect to the next parameter, that is, Fincash Rating, it can be said that SBI Contra Fund is rated as 3-Star, whereas Invesco India Contra Fund is rated as 4-Star. In case of Net Asset Value, SBI Contra Fund's NAV as on 19th July 2018 is INR 106.675 and the NAV of Invesco India Contra Fund is INR 46.39. The table given below summarizes the details of basics section.
Parameters Basics NAV Net Assets (Cr) Launch Date Rating Category Sub Cat. Category Rank Risk Expense Ratio Sharpe Ratio Information Ratio Alpha Ratio Benchmark Exit Load SBI Contra Fund
Growth
Fund Details ₹343.454 ↓ -1.44 (-0.42 %) ₹26,777 on 31 Mar 24 6 May 05 ☆☆☆ Equity Contra 48 Moderately High 1.92 3.06 1.84 5.7 Not Available 0-1 Years (1%),1 Years and above(NIL) Invesco India Contra Fund
Growth
Fund Details ₹110.37 ↑ 0.28 (0.25 %) ₹13,903 on 31 Mar 24 11 Apr 07 ☆☆☆☆ Equity Contra 11 Moderately High 1.8 2.77 0.17 2.61 Not Available 0-1 Years (1%),1 Years and above(NIL)
The performance section compares the Compounded Annual Growth Rate or CAGR returns between both the schemes at different time periods. With respect to performance, it can be said there is not much difference in the performance of both the schemes. However, in many instances, SBI Contra Fund leads the race. The performance of both the schemes at different time periods is shown below as follows.
Parameters Performance 1 Month 3 Month 6 Month 1 Year 3 Year 5 Year Since launch SBI Contra Fund
Growth
Fund Details 4.6% 8% 22.2% 48.1% 31.4% 25.1% 17.4% Invesco India Contra Fund
Growth
Fund Details 5.8% 5.8% 20.7% 43.8% 21.9% 17.9% 15.1%
Talk to our investment specialist
This section deals with the absolute returns generated by both the funds in each year. In this case, we can see that there is a difference in the performance of both the schemes. In many situations, Invesco India Contra Fund has performed better than SBI Contra Fund. The yearly performance of both the funds is tabulated as follows.
Parameters Yearly Performance 2023 2022 2021 2020 2019 SBI Contra Fund
Growth
Fund Details 38.2% 12.8% 49.9% 30.6% -1% Invesco India Contra Fund
Growth
Fund Details 28.8% 3.8% 29.6% 21.2% 5.9%
This is the last section in the comparison of both the funds. In this section, the parameters such as AUM, Minimum SIP and Lumpsum Investment, and Exit Load are compared. To begin with the minimum SIP investment, both the schemes have the same monthly SIP amounts, i.e., INR 500. Similarly, in case of minimum lumpsum investment, the amount for both the schemes are same i.e, INR 5,000. Coming to the AUM, the AUM of SBI Contra Fund as on 30th June 2018 was INR 1,605 crores and the AUM of Invesco India Contra Fund was INR 1,868 crores. The table given below summarizes the other details for both the schemes.
Parameters Other Details Min SIP Investment Min Investment Fund Manager SBI Contra Fund
Growth
Fund Details ₹500 ₹5,000 Dinesh Balachandran - 5.9 Yr. Invesco India Contra Fund
Growth
Fund Details ₹500 ₹5,000 Amit Ganatra - 0.33 Yr.
SBI Contra Fund
Growth
Fund Details Growth of 10,000 investment over the years.
Date Value 31 Mar 19 ₹10,000 31 Mar 20 ₹6,811 31 Mar 21 ₹13,833 31 Mar 22 ₹18,032 31 Mar 23 ₹20,427 31 Mar 24 ₹30,215 Invesco India Contra Fund
Growth
Fund Details Growth of 10,000 investment over the years.
Date Value 31 Mar 19 ₹10,000 31 Mar 20 ₹7,478 31 Mar 21 ₹12,924 31 Mar 22 ₹15,469 31 Mar 23 ₹15,626 31 Mar 24 ₹22,282
SBI Contra Fund
Growth
Fund Details Asset Allocation
Asset Class Value Cash 15.93% Equity 83.07% Debt 1% Equity Sector Allocation
Sector Value Financial Services 19.01% Basic Materials 10.73% Industrials 10.27% Consumer Cyclical 9.89% Utility 7.76% Technology 7.74% Energy 6.91% Health Care 6.37% Consumer Defensive 2.1% Communication Services 1.55% Real Estate 0.74% Top Securities Holdings / Portfolio
Name Holding Value Quantity State Bank of India (Financial Services)
Equity, Since 31 Dec 10 | SBIN3% ₹767 Cr 10,254,269 GAIL (India) Ltd (Utilities)
Equity, Since 28 Feb 21 | 5321553% ₹750 Cr 41,173,788 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Aug 16 | HDFCBANK3% ₹736 Cr 5,247,072 Cognizant Technology Solutions Corp Class A (Technology)
Equity, Since 28 Feb 23 | CTSH3% ₹649 Cr 990,530 ICICI Bank Ltd (Financial Services)
Equity, Since 28 Feb 17 | ICICIBANK2% ₹556 Cr 5,281,550 Axis Bank Ltd (Financial Services)
Equity, Since 31 May 19 | 5322152% ₹527 Cr 4,904,255
↑ 800,000 Whirlpool of India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | 5002382% ₹508 Cr 4,040,000
↑ 4,040,000 91 DTB 02052024
Sovereign Bonds | -2% ₹494 Cr 50,000,000
↑ 10,000,000 Petronet LNG Ltd (Energy)
Equity, Since 31 May 23 | 5325222% ₹478 Cr 17,474,315 Tata Steel Ltd (Basic Materials)
Equity, Since 31 Jul 22 | TATASTEEL2% ₹470 Cr 33,345,525 Invesco India Contra Fund
Growth
Fund Details Asset Allocation
Asset Class Value Cash 1.43% Equity 98.57% Equity Sector Allocation
Sector Value Financial Services 29.53% Industrials 14.27% Consumer Cyclical 13.3% Technology 12.07% Health Care 8.78% Utility 8.63% Basic Materials 3.9% Energy 3.08% Real Estate 2.17% Consumer Defensive 1.47% Communication Services 1.37% Top Securities Holdings / Portfolio
Name Holding Value Quantity ICICI Bank Ltd (Financial Services)
Equity, Since 31 May 17 | ICICIBANK6% ₹840 Cr 7,986,079 HDFC Bank Ltd (Financial Services)
Equity, Since 30 Apr 14 | HDFCBANK5% ₹718 Cr 5,114,242 Infosys Ltd (Technology)
Equity, Since 30 Sep 13 | INFY5% ₹704 Cr 4,205,397 NTPC Ltd (Utilities)
Equity, Since 31 Mar 21 | 5325555% ₹696 Cr 20,752,875
↓ -1,135,056 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Sep 20 | LT3% ₹451 Cr 1,295,765 State Bank of India (Financial Services)
Equity, Since 28 Feb 21 | SBIN3% ₹395 Cr 5,275,516 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Dec 18 | BEL3% ₹369 Cr 17,995,746 HCL Technologies Ltd (Technology)
Equity, Since 30 Apr 19 | HCLTECH3% ₹368 Cr 2,212,276 Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 30 Nov 16 | SUNPHARMA3% ₹346 Cr 2,191,359 Axis Bank Ltd (Financial Services)
Equity, Since 30 Jun 20 | 5322152% ₹337 Cr 3,136,159
Therefore, from the above pointers, it can be said that both the schemes exhibit different attributes with respect to different parameters. However, when it comes to investing, it is always advisable that people should go through the scheme’s modalities completely before doing the actual investment. Additionally, they should also check whether the scheme’s approach is in-line with your investment objective. To get further clarification, you can even consult a financial advisor. This will help you ensure that your investment is safe as well as it paves way for wealth creation.